LPL Financial
KPRX icon

LPL Financial’s Kiora Pharmaceuticals KPRX Stock Holding History

LPL Financial’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9K Buy
+12,500
New +$31.4K ﹤0.01% 6078

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LPL Financial's KPRX Position: Q2 2026 in Review

LPL Financial opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 12,500 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #6078 among its holdings.

19 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • LPL Financial held 12,500 shares of Kiora Pharmaceuticals worth $32.9K as of Q2 2026.
  • Kiora Pharmaceuticals was a new LPL Financial position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6078 holding.
  • 19 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.